Page last updated: 2024-08-02 20:13:38

barbamide

Description

barbamide: from the marine Carribean cyanobacterium Lyngbya majuscula; structure in first source [MeSH]

Barbamide : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID11465376
CHEBI ID80028
MeSH IDM0263878

Synonyms (5)

Synonym
barbamide
CHEBI:80028
Q27149173
DTXSID901334663
(e,5s)-6,6,6-trichloro-3-methoxy-n,5-dimethyl-n-[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide

Drug Classes (1)

ClassDescription
fatty amideA monocarboxylic acid amide derived from a fatty acid.

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
1-phenyl-2-palmitoylamino-3-morpholino-1-propanolbenzyl alcohols;
fatty amide;
morpholines;
secondary alcohol;
tertiary amino compound
00low000000
lauric acid diethanolamidefatty amide00low000000
valnoctamidefatty amide00low000000
diethylallylacetamidefatty amide00low000000
dipropylacetamidefatty amidegeroprotector;
metabolite;
teratogenic agent
00low000000
n-myristoylglycinefatty amide;
N-acylglycine
human blood serum metabolite;
human urinary metabolite
00low000000
n,n'-diallyltartardiamidefatty amide00low000000
ici 162846fatty amide00low000000
n-palmitoylglycinefatty amide;
N-acylglycine 16:0
human metabolite;
marine metabolite
00low000000
3-methyl-N-(2-phenylethyl)-2-butenamidefatty amide00low000000
N-[[(5-chloro-2-pyridinyl)amino]-sulfanylidenemethyl]-3-methylbutanamidefatty amide00low000000
N-[(2-adamantylamino)-sulfanylidenemethyl]hexanamidefatty amide00low000000
N-[[(1-oxo-3-phenylpropyl)hydrazo]-sulfanylidenemethyl]pentanamidefatty amide00low000000
N,N'-bis(3-phenylpropyl)butanediamidefatty amide00low000000
3-(2-furanyl)-N-[3-(2-furanyl)-4-methylpentyl]-4-phenylbutanamidefatty amide00low000000
arachidonyl dopaminecatechols;
fatty amide;
N-(fatty acyl)-dopamine;
secondary carboxamide
00low000000
n-oleoyldopaminecatechols;
fatty amide;
N-(fatty acyl)-dopamine;
secondary carboxamide
TRPV1 agonist00low000000
n-arachidonylglycinefatty amide;
N-acylglycine
00low000000
arachidonyl-2-chloroethylamidefatty amide;
organochlorine compound;
secondary carboxamide;
synthetic cannabinoid
CB1 receptor agonist;
CB2 receptor agonist;
neuroprotective agent
00low000000
pellitorinefatty amidemetabolite00low000000
oleoylanilideanilide;
fatty amide
00low000000
am-356fatty amide00low000000
n-oleoylglycinefatty amide;
N-acylglycine 18:1
metabolite00low000000
linoleylanilideanilide;
fatty amide
00low000000
sanshoolfatty amide00low000000
(2E,4E)-N-isobutyl-2,4-dodecadienamidefatty amidemetabolite00low000000
kalkitoxinfatty amide00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cetyl alcoholhexadecanol;
long-chain primary fatty alcohol
algal metabolite;
flavouring agent;
human metabolite;
plant metabolite
201820186.0low000010
leucineamino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
2002200619.3medium000300
carvonebotanical anti-fungal agent;
carvones
allergen201820186.0low000010
tetrahydrofurancyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound
polar aprotic solvent201820186.0low000010
thiazoles1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1950202319.1high011642
pyrrolnitrinalkaloid;
C-nitro compound;
monochlorobenzenes;
pyrroles
antifungal drug;
bacterial metabolite
201820186.0low000010
rutheniumiron group element atom;
platinum group metal atom
2011201113.0low000010
chlorinediatomic chlorine;
gas molecular entity
bleaching agent2005200519.0low000100
rebeccamycinindolocarbazole;
N-glycosyl compound;
organic heterohexacyclic compound;
organochlorine compound
201820186.0low000010
naphthoquinones2004200420.0low000100
curacin athiazoles2011201113.0low000010
dysidenin1,3-thiazoles;
organochlorine compound;
secondary carboxamide;
tertiary carboxamide
animal metabolite;
marine metabolite;
toxin
2011201113.0medium000010
pacidamycin d201820186.0high000010
enterocin2004200420.0low000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Drug-Induced Stevens Johnson Syndrome01950195074.0high010000
Erythema01950195074.0high010000
Stevens-Johnson Syndrome01950195074.0high010000